Head-To-Head Contrast: Matthews International (MATW) and DS Healthcare Group (DSKX)

Matthews International (NASDAQ: MATW) and DS Healthcare Group (OTCMKTS:DSKX) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for Matthews International and DS Healthcare Group, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Matthews International 0 0 3 0 3.00
DS Healthcare Group 0 0 0 0 N/A

Matthews International currently has a consensus target price of $83.50, suggesting a potential upside of 60.58%. Given Matthews International’s higher possible upside, analysts plainly believe Matthews International is more favorable than DS Healthcare Group.

Earnings and Valuation

This table compares Matthews International and DS Healthcare Group’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Matthews International $1.52 billion 1.11 $74.36 million $3.07 16.94
DS Healthcare Group $12.95 million 0.01 -$6.93 million ($0.28) -0.02

Matthews International has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Matthews International, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

78.8% of Matthews International shares are owned by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are owned by institutional investors. 3.8% of Matthews International shares are owned by company insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Matthews International and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Matthews International 6.46% 15.09% 5.15%
DS Healthcare Group -62.31% -1,304.25% -117.85%

Risk and Volatility

Matthews International has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 8.77, suggesting that its stock price is 777% more volatile than the S&P 500.

Dividends

Matthews International pays an annual dividend of $0.76 per share and has a dividend yield of 1.5%. DS Healthcare Group does not pay a dividend. Matthews International pays out 24.8% of its earnings in the form of a dividend. Matthews International has raised its dividend for 6 consecutive years.

Summary

Matthews International beats DS Healthcare Group on 12 of the 15 factors compared between the two stocks.

About Matthews International

Matthews International Corporation is a provider of brand solutions, memorialization products and industrial technologies. The Company operates through three segments: SGK Brand Solutions, Memorialization and Industrial Technologies. The SGK Brand Solutions segment provides brand development, deployment and delivery (consisting of brand management, printing plates and cylinders, pre-media services and imaging services for consumer packaged goods and retail customers, merchandising display systems, and marketing and design services). The Memorialization segment manufactures and markets a line of memorialization products used primarily in cemeteries, funeral homes and crematories. The Industrial Technologies segment designs, manufactures and distributes a range of marking, coding and industrial automation solutions, order fulfillment systems and related consumables.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Matthews International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matthews International and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit